Nam Dai Vo, MD | |
10 Mcdowell St, Asheville, NC 28801-4104 | |
(828) 258-8545 | |
(828) 254-0714 |
Full Name | Nam Dai Vo |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 23 Years |
Location | 10 Mcdowell St, Asheville, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255382214 | NPI | - | NPPES |
5904808 | Medicaid | NC | |
143GY | Other | NC | NC BLUE CROSS PROVIDER # |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 200401147 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Asheville Kidney Center Inc | Asheville, NC | Dialysis facility |
Total Renal Care Of North Carolina, Llc | Asheville, NC | Dialysis facility |
Sylva Dialysis Center | Sylva, NC | Dialysis facility |
Mcdowell County Dialysis | Marion, NC | Dialysis facility |
Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
The Mcdowell Hospital | Marion, NC | Hospital |
Harris Regional Hospital | Sylva, NC | Hospital |
Haywood Regional Medical Center | Clyde, NC | Hospital |
Angel Medical Center | Franklin, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mountain Kidney And Hypertension Associates Pa | 0244213502 | 17 |
Cherokee Indian Hospital Authority | 2062320393 | 20 |
News Archive
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Aiming to reduce cancer risk, improve the understanding of cancer outcomes, and promote cancer health equity in our most vulnerable populations at the community level, the Rutgers School of Public Health and Rutgers Cancer Institute of New Jersey have recruited Anita Y. Kinney, PhD, as Director of the Center of Cancer Health Disparities at the Rutgers School of Public Health and Associate Director of Cancer Health Equity and Engagement at Rutgers Cancer Institute.
The Citywide 1-1 Team from Sheffield's Jessop Wing has been shortlisted in the prestigious RCM Annual Midwifery Awards.
Omeros Corporation today announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain.
A decision could be issued any day. Also still in the mix is the court's ruling on a First Amendment challenge to a Massachusetts law that established a 35-foot buffer zone to restrict demonstrators outside of abortion clinics.
› Verified 3 days ago
Entity Name | Mountain Kidney & Hypertension Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477516698 PECOS PAC ID: 0244213502 Enrollment ID: O20040609000552 |
News Archive
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Aiming to reduce cancer risk, improve the understanding of cancer outcomes, and promote cancer health equity in our most vulnerable populations at the community level, the Rutgers School of Public Health and Rutgers Cancer Institute of New Jersey have recruited Anita Y. Kinney, PhD, as Director of the Center of Cancer Health Disparities at the Rutgers School of Public Health and Associate Director of Cancer Health Equity and Engagement at Rutgers Cancer Institute.
The Citywide 1-1 Team from Sheffield's Jessop Wing has been shortlisted in the prestigious RCM Annual Midwifery Awards.
Omeros Corporation today announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain.
A decision could be issued any day. Also still in the mix is the court's ruling on a First Amendment challenge to a Massachusetts law that established a 35-foot buffer zone to restrict demonstrators outside of abortion clinics.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Nam Dai Vo, MD 10 Mcdowell St, Asheville, NC 28801-4104 Ph: (828) 258-8545 | Nam Dai Vo, MD 10 Mcdowell St, Asheville, NC 28801-4104 Ph: (828) 258-8545 |
News Archive
AiCuris announced today the presentation of preclinical and Phase 1 data on AIC316 at the Antivirals Congress in Amsterdam, Netherlands, from 7th – 9th of November 2010. AIC316 is a novel anti-HSV drug currently in clinical phase 2 testing.
Aiming to reduce cancer risk, improve the understanding of cancer outcomes, and promote cancer health equity in our most vulnerable populations at the community level, the Rutgers School of Public Health and Rutgers Cancer Institute of New Jersey have recruited Anita Y. Kinney, PhD, as Director of the Center of Cancer Health Disparities at the Rutgers School of Public Health and Associate Director of Cancer Health Equity and Engagement at Rutgers Cancer Institute.
The Citywide 1-1 Team from Sheffield's Jessop Wing has been shortlisted in the prestigious RCM Annual Midwifery Awards.
Omeros Corporation today announced that the European Commission (EC) has granted marketing authorization for Omidria (phenylephrine and ketorolac injection) 1% / 0.3% in the European Union (EU) for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain.
A decision could be issued any day. Also still in the mix is the court's ruling on a First Amendment challenge to a Massachusetts law that established a 35-foot buffer zone to restrict demonstrators outside of abortion clinics.
› Verified 3 days ago
Dr. William R Harlan Iii, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 191 Biltmore Ave, Asheville, NC 28801 Phone: 828-254-0881 Fax: 828-254-1614 | |
Dr. Nellie E. L. Fleming, MD Nephrology Medicare: May Accept Medicare Assignments Practice Location: 509 Biltmore Ave, Asheville Hospitalist Group, Asheville, NC 28801 Phone: 828-213-4411 Fax: 828-285-9740 | |
Dr. Wade H Saunders Iii, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 5 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-274-6000 Fax: 828-277-6350 | |
Marianne Soufas, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 68 Sweeten Creek Rd, Asheville, NC 28803 Phone: 828-274-9567 Fax: 828-255-2865 | |
Dr. Bryan J Pace, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5 Vanderbilt Park Dr, Asheville, NC 28803 Phone: 828-274-6000 Fax: 828-274-6025 | |
Zachary Dillon Glenn, DO Nephrology Medicare: Medicare Enrolled Practice Location: 509 Biltmore Ave, Asheville, NC 28801 Phone: 828-213-1111 | |
Dr. Jeffrey Tyler Ramsey, DO Nephrology Medicare: Medicare Enrolled Practice Location: 123 Hendersonville Rd, Asheville, NC 28803 Phone: 828-407-2415 Fax: 828-412-4171 |